Koyfin Home > Directory > Health Care > Biogen Inc > Gross Margin

Biogen Inc Gross Margin Chart (BIIB)

Biogen Inc annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Biogen Inc Gross Margin for the quarter ending September 09, 2020 was $87m a -1.30% decrease of -1m year over year
  • Biogen Inc Gross Margin for the last 12 months ending September 09, 2020 was $88m a 1.42% increase of 1m year over year
  • Biogen Inc Annual Gross Margin for 2019 was $86m a -0.11% decrease of 0m from 2018
  • Biogen Inc Annual Gross Margin for 2018 was $86m a -0.26% decrease of 0m from 2017
  • Biogen Inc Annual Gross Margin for 2017 was $87m a -0.88% decrease of -1m from 2016
Other Margins & Efficiency Metrics:
  • Biogen Inc EBITDA Margin for the quarter ending December 12, 2018 was $49m a -13.52% decrease of -7m year over year
  • Biogen Inc Return on Capital % for the quarter ending December 12, 2018 was 20.45 a -0.53% decrease of -0.11 year over year
  • Biogen Inc Return on Equity % for the quarter ending December 12, 2018 was 28.21 a -24.67% decrease of -6.96 year over year
View Chart On Koyfin

Quarterly BIIB Gross Margin Data

09/2020$87m
06/2020$89m
03/2020$87m
12/2019$88m
09/2019$88m
06/2019$87m
03/2019$83m
12/2018$86m
09/2018$87m
06/2018$87m

Annual BIIB Gross Margin Data

2019$86m
2018$86m
2017$87m
2016$87m
2015$88m
2014$88m
2013$88m
2012$90m
2011$91m
2010$92m